We checked all 31+ operators marketing ibogaine treatment in Mexico: their pricing, their medical claims, their staff and their complaint records. 22 made the directory. Here is everything we found, free.
The Tijuana border corridor holds the largest cluster in the world; the Caribbean coast holds the highest-profile clinics.
Editorial picks carry the highest safety-disclosure scores. Paid placements are always labeled.
Tijuana
Cancún
Morelos (Mexico City area)
Los Cabos & La PazIbogaine is unscheduled in Mexico and Schedule I in the United States, which means an entire treatment industry operates across the border with no regulator checking claims. Some clinics run hospital-grade operations with cardiologists on staff. Some administer a cardiotoxic substance while stating, in writing, that it is not a medical treatment. Marketing does not distinguish them. Verification does.
We publish what each clinic discloses about the five safety practices the 2016 GITA clinical guidelines call for (EKG screening, ACLS-certified staff, named physicians, monitoring during dosing, and hospital proximity), every published price with dates, and the complaint records other directories leave out. Nine operators did not make this list; we say exactly which, and why.
Ibogaine is unscheduled in Mexico. It is not listed under Article 245 of the Ley General de Salud, which is why clinics can operate openly. That is different from being approved: COFEPRIS, the Mexican health regulator, has not endorsed ibogaine as a medicine. In the United States it remains a Schedule I controlled substance.
Published prices in July 2026 run from about $3,500 for short wellness-style programs to $30,000 for extended medical detox programs. Most standard 7-day detox programs fall between $7,500 and $15,500. Around half of the clinics we track publish no pricing at all; see our cost guide for the full comparison table.
Ibogaine carries a real cardiac risk. It blocks the hERG potassium channel, which prolongs the QT interval and can trigger a dangerous arrhythmia called torsades de pointes. At least 33 deaths have been reported in the scientific literature, most in settings without cardiac monitoring or life support. This is why pre-treatment EKG screening and continuous monitoring matter more than any amenity a clinic advertises.
At minimum: a 12-lead EKG reviewed for QT interval, bloodwork including electrolytes and liver function, and a psychiatric and medication history. Reputable clinics refuse patients with certain cardiac conditions. If a clinic will take you without an EKG, treat that as a disqualifying red flag.
Most patients travel to Mexico for opioid detox, because ibogaine is reported to sharply reduce acute withdrawal. Clinics also treat alcohol and stimulant dependence, and a growing number of veterans seek it for PTSD and traumatic brain injury after a 2024 Stanford Medicine study reported large symptom reductions in an open-label veteran cohort. Efficacy evidence is still early and mostly uncontrolled.
Ibogaine has been listed on Schedule I of the Controlled Substances Act since the hallucinogen scheduling of the early 1970s, meaning US law treats it as having no accepted medical use. That is now being revisited: Texas created a $50 million fund in 2025 to run FDA-track clinical trials, and several states have introduced ibogaine research bills.
